Novartis releases new data on benefits of Kesimpta in relapsing multiple sclerosis EP News Bureau Sep 24, 2025 Novartis has released new data from two Kesimpta (ofatumumab) studies in relapsing multiple sclerosis (RMS) that will be presented…
